Status:
COMPLETED
Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy
Lead Sponsor:
Innovative Medical
Conditions:
Dry Eye Syndromes
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the effect of topical cyclosporine ophthalmic solution 0.05% (Restasis, Allergan) on the signs and symptoms of dry eye in patients undergoing LASIK or photoref...
Eligibility Criteria
Inclusion
- Males or females \> 18 years old
- Mild-moderate symptoms of dry eye prior to surgery
- Scheduled to undergo bilateral LASIK or PRK
- Likely to complete all study visits and able to provide informed consent
Exclusion
- Prior use of topical cyclosporine within the last 1 year
- Known contraindications to any study medication or ingredients
- Female of child bearing potential not using reliable methods of birth control, or pregnant or lactating females.
- Ocular disorders
- Active ocular diseases or uncontrolled systemic disease
- Active ocular allergies
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
93 Patients enrolled
Trial Details
Trial ID
NCT00349440
Start Date
September 1 2006
End Date
September 1 2008
Last Update
September 26 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Southeastern Laser and Refractive Surgery
Greensboro, North Carolina, United States, 27410